文献速递眼底病与葡萄膜炎

ANGPTL4通过JNK/c-Jun和JAK2/STAT5通路上调VEGF和sVCAM1

Angiopoietin-Like 4 Induces Upregulation of VEGF and sVCAM1 Through JNK/c-Jun and JAK2/STAT5 Signaling Pathways.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究在永生化小鼠视网膜内皮细胞(iRECs)中,用磷酸激酶蛋白组学阵列分析重组ANGPTL4激活的信号通路,并通过药物抑制和siRNA敲低验证其在血管生成和效应分子上调中的作用,最后在C57BL/6J小鼠眼内递送ANGPTL4进行验证。结果显示ANGPTL4激活JNK/c-Jun和JAK2/STAT5轴,抑制任一通路均显著减少ANGPTL4诱导的血管生成,且VEGF和sVCAM1的分泌依赖这两条通路。

要点

  • ANGPTL4在视网膜内皮细胞中激活JNK/c-Jun和JAK2/STAT5信号轴。
  • 抑制JNK/c-Jun或JAK2/STAT5通路显著减少ANGPTL4诱导的血管生成。
  • ANGPTL4诱导的VEGF和sVCAM1分泌依赖JNK/c-Jun和JAK2/STAT5通路。

核心结论

  • ANGPTL4作为信号枢纽整合不同信号激活JNK/c-Jun和JAK2/STAT5,上调VEGF和sVCAM1等关键致病蛋白。
  • JNK/c-Jun和JAK2/STAT5是视网膜中ANGPTL4信号此前未被识别的效应通路。

研究设计与样本

  • 使用磷酸激酶蛋白组学阵列在永生化小鼠视网膜内皮细胞(iRECs)中映射重组ANGPTL4激活的通路。
  • 通过药物抑制和siRNA介导的敲低评估候选信号通路在ANGPTL4驱动的血管生成和效应分子上调中的作用。
  • 在C57BL/6J小鼠眼内递送ANGPTL4后验证发现。

主要发现

  • ANGPTL4在iRECs中强烈激活JNK/c-Jun和JAK2/STAT5轴,该特征在体内神经感觉视网膜中重现。
  • 抑制任一通路显著减少ANGPTL4诱导的血管生成。
  • ANGPTL4诱导VEGF、sVCAM1、TIM-1和proliferin的分泌,但仅VEGF和sVCAM1依赖JNK/c-Jun和JAK2/STAT5。

临床怎么用

  • 提示JNK/c-Jun和JAK2/STAT5通路可能作为ANGPTL4相关视网膜新生血管疾病的潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Angiopoietin-like protein 4 (ANGPTL4) is a multifunctional cytokine regulating angiogenesis, vascular permeability, and inflammation that is elevated, along with vascular endothelial growth factor (VEGF), in multiple ocular neovascular disorders, including ischemic retinopathies and neovascular age-related macular degeneration. However, the downstream signaling pathways that contribute to the effects of ANGPTL4 in ocular disease remain unclear. METHODS: A phospho-kinase Proteome Profiler array was used to map pathways activated by recombinant ANGPTL4 in immortalized murine retinal endothelial cells (iRECs). Candidate signaling routes were assessed using pharmacologic inhibition and siRNA-mediated knockdown to define their roles in ANGPTL4-driven angiogenesis and effector upregulation. Findings were validated following intraocular ANGPTL4 delivery in C57BL/6J mice. RESULTS: ANGPTL4 robustly activated the c-Jun N-terminal kinase (JNK)/c-Jun and Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) axes in iRECs, a signature recapitulated in neurosensory retina in vivo. Inhibition of either pathway significantly reduced ANGPTL4-induced angiogenesis, identifying these pathways as critical effectors of ANGPTL4 signaling. ANGPTL4 induced secretion of VEGF, soluble vascular cell adhesion molecule 1 (sVCAM1), T-cell immunoglobulin and mucin domain 1 (TIM-1), and proliferin; however, only VEGF and sVCAM1 depended on JNK/c-Jun and JAK2/STAT5. CONCLUSIONS: ANGPTL4 functions as a signaling hub that integrates different cues to activate JNK/c-Jun and JAK2/STAT5 and upregulate the expression of key pathogenic proteins including VEGF and sVCAM1. This work establishes these cascades as previously unrecognized effectors of ANGPTL4 signaling in the retina and brings important insight into the critical role that ANGPTL4 plays in neovascular retinal disease.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Osorio DL, Kumar A, Choi A, et al. Angiopoietin-Like 4 Induces Upregulation of VEGF and sVCAM1 Through JNK/c-Jun and JAK2/STAT5 Signaling Pathways. Invest Ophthalmol Vis Sci. 2026. PMID: 42752553. doi:10.1167/iovs.67.11.36

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。